Related Experiment Video
Updated: Feb 5, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
Thomas J van Ee1, Heleen H Van Acker2, Tom G van Oorschot3
1Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen 6525 GA, The Netherlands. Thomas.vanEe@radboudumc.nl.
New research highlights BDCA1+CD14+ immunosuppressive cells as a key factor impacting dendritic cell (DC) vaccine efficacy and tumor immune evasion in various cancers. Targeting these cells may improve cancer immunotherapy outcomes.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Dendritic cell (DC) vaccines show promise in cancer immunotherapy but face challenges.
- Tumor immune evasion and vaccine quality significantly affect DC vaccine efficacy.
- BDCA1+CD14+ immunosuppressive cells are recently characterized and implicated in both vaccine quality and immune evasion.
Purpose of the Study:
- To review the presence and significance of BDCA1+CD14+ cells in solid and leukemic cancers.
- To investigate the potential of BDCA1+CD14+ cells as therapeutic targets for improving cancer immunotherapy.
- To explore the clinical significance and cell biology of BDCA1+CD14+ cells.
Main Methods:
- Literature review summarizing findings on BDCA1+CD14+ cells in solid cancers.
- Evaluation of BDCA1+CD14+ cell presence in leukemic cancers.
- Analysis of preliminary results correlating BDCA1+CD14+ cells with myeloid leukemia clinical features.
Main Results:
- BDCA1+CD14+ cells are present in a broad spectrum of cancers, potentially hampering DC vaccine efficacy.
- These cells can suppress immune responses systemically and at the tumor site.
- Preliminary data suggest a correlation between BDCA1+CD14+ cells and clinical features of acute and chronic myeloid leukemia.
Conclusions:
- BDCA1+CD14+ cells represent a significant factor in cancer immune evasion and DC vaccine effectiveness.
- Further research into the differentiation and biology of BDCA1+CD14+ cells is warranted.
- Targeting BDCA1+CD14+ cells offers a potential strategy to enhance cancer immunotherapy outcomes.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Standard Electrode Potentials
The Resting Membrane Potential
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

